English
This article is from Indian Journal of Endocrinology and Metabolism , volume 18 . Abstract Context:: Tumoral calcinosis is a disorder of phosphate metabolism characterized by ectopic calcification around major joints. Surgery is the current treatment of choice, but a suboptimal choice in recurrent and multicentric lesions. Aims:: To evaluate the efficacy of bisphosphonates for the management of tumoral calcinosis on optimized medical treatment. Settings and Design:: The study was done in the endocrine department of a tertiary care hospital in South India. We prospectively studied two patients with recurrent tumoral calcinosis who had failed therapy with phosphate lowering measures. Materials and Methods:: After informed consent, we treated both patients with standard age adjusted doses of bisphosphonates for 18 months. The response was assessed by X ray and whole body 99mTc-methylene diphosphonate bone scan at the beginning of therapy and at the end of 1 year. We also estimated serum phosphate levels and urinary phosphate to document serial changes. Results:: Two patients (aged 19 and 5 years) with recurrent idiopathic hyperphosphatemic tumoral calcinosis, following surgery were st
Sign in with your free account to read, download EPUBs or listen.
Ebook · Differential response of idiopathic sporadic tumoral calcinosis to bisphosphonates. · Balachandran, Karthik, Kamalanathan, Sadishkumar, Sahoo, Jaya Prakash, Das, Ashok Kumar, Halanaik, Dhanapathi · Internet Archive